Biolife Solutions [BLFS] vs Becton, Dickinson [BDX] Detailed Stock Comparison
Biolife Solutions
NASDAQ
Loading...
Becton, Dickinson
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Biolife Solutions wins in 5 metrics, Becton, Dickinson wins in 13 metrics, with 0 ties. Becton, Dickinson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biolife Solutions | Becton, Dickinson | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -60.73 | 35.20 | Biolife Solutions |
| Price-to-Book Ratio | 3.62 | 2.17 | Becton, Dickinson |
| Debt-to-Equity Ratio | 6.86 | 75.93 | Biolife Solutions |
| PEG Ratio | 2.28 | 1.85 | Becton, Dickinson |
| EV/EBITDA | -961.57 | 12.46 | Biolife Solutions |
| Profit Margin (TTM) | -5.92% | 7.41% | Becton, Dickinson |
| Operating Margin (TTM) | -4.41% | 17.81% | Becton, Dickinson |
| EBITDA Margin (TTM) | N/A | 17.81% | N/A |
| Return on Equity | -5.66% | 6.18% | Becton, Dickinson |
| Return on Assets (TTM) | -0.80% | 3.96% | Becton, Dickinson |
| Free Cash Flow (TTM) | $4.90M | $3.07B | Becton, Dickinson |
| Dividend Yield | N/A | 1.80% | N/A |
| 1-Year Return | 20.97% | -18.00% | Biolife Solutions |
| Price-to-Sales Ratio (TTM) | 13.48 | 2.58 | Becton, Dickinson |
| Enterprise Value | $1.20B | $73.77B | Becton, Dickinson |
| EV/Revenue Ratio | 12.86 | 3.45 | Becton, Dickinson |
| Gross Profit Margin (TTM) | 64.64% | 47.81% | Biolife Solutions |
| Revenue per Share (TTM) | $2 | $74 | Becton, Dickinson |
| Earnings per Share (Diluted) | $-0.40 | $5.47 | Becton, Dickinson |
| Beta (Stock Volatility) | 1.95 | 0.28 | Becton, Dickinson |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Biolife Solutions vs Becton, Dickinson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biolife Solutions | 3.95% | 4.63% | 4.27% | 21.24% | 32.46% | 4.43% |
| Becton, Dickinson | 0.73% | 1.57% | 1.23% | 11.05% | -3.44% | -14.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biolife Solutions | 20.97% | 34.75% | -2.95% | 1,120.54% | 2,689.80% | 1,852.86% |
| Becton, Dickinson | -18.00% | -13.69% | -16.12% | 42.43% | 161.11% | 286.55% |
News Based Sentiment: Biolife Solutions vs Becton, Dickinson
Biolife Solutions
News based Sentiment: POSITIVE
BioLife Solutions experienced a highly positive month with an analyst upgrade, increased revenue guidance, and a suggestion of significant undervaluation. Strong institutional ownership and a positive stock reaction further reinforce a bullish outlook, making this a significant month for the company's investment narrative.
Becton, Dickinson
News based Sentiment: POSITIVE
BDX delivered a strong October, exceeding earnings expectations and raising guidance, fueled by strategic investments in pharmacy automation and continued institutional support. While insider selling is a minor concern, the overall narrative points to positive momentum and growth potential, making it a significant month for investors.
Performance & Financial Health Analysis: Biolife Solutions vs Becton, Dickinson
| Metric | BLFS | BDX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.26B | $55.18B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 345,300 | 1,365,580 |
| 90 Day Avg. Volume | 384,577 | 1,558,670 |
| Last Close | $27.34 | $193.93 |
| 52 Week Range | $19.10 - $29.55 | $163.33 - $251.99 |
| % from 52W High | -7.48% | -23.04% |
| All-Time High | $1,382.50 (Nov 04, 1991) | $287.32 (Jul 24, 2023) |
| % from All-Time High | -98.02% | -32.50% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | 0.10% |
| Quarterly Earnings Growth | -0.10% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.07% |
| Operating Margin (TTM) | -0.04% | 0.18% |
| Return on Equity (TTM) | -0.06% | 0.06% |
| Debt to Equity (MRQ) | 6.86 | 75.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.26 | $88.87 |
| Cash per Share (MRQ) | $1.71 | $2.64 |
| Operating Cash Flow (TTM) | $15.54M | $3.25B |
| Levered Free Cash Flow (TTM) | $30.58M | $3.37B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.80% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Biolife Solutions vs Becton, Dickinson
| Metric | BLFS | BDX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -60.73 | 35.20 |
| Forward P/E | -93.93 | 12.24 |
| PEG Ratio | 2.28 | 1.85 |
| Price to Sales (TTM) | 13.48 | 2.58 |
| Price to Book (MRQ) | 3.62 | 2.17 |
| Market Capitalization | ||
| Market Capitalization | $1.26B | $55.18B |
| Enterprise Value | $1.20B | $73.77B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.86 | 3.45 |
| Enterprise to EBITDA | -961.57 | 12.46 |
| Risk & Other Metrics | ||
| Beta | 1.95 | 0.28 |
| Book Value per Share (MRQ) | $7.26 | $88.87 |
Financial Statements Comparison: Biolife Solutions vs Becton, Dickinson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BLFS | BDX |
|---|---|---|
| Revenue/Sales | $23.94M | $5.51B |
| Cost of Goods Sold | $8.16M | $2.88B |
| Gross Profit | $15.79M | $2.63B |
| Research & Development | $2.20M | $297.00M |
| Operating Income (EBIT) | $-1.22M | $979.00M |
| EBITDA | $166,000 | $1.57B |
| Pre-Tax Income | $-434,000 | $703.00M |
| Income Tax | $14,000 | $129.00M |
| Net Income (Profit) | $-448,000 | $574.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BLFS | BDX |
|---|---|---|
| Cash & Equivalents | $66.95M | $667.00M |
| Total Current Assets | $131.13M | $8.67B |
| Total Current Liabilities | $27.72M | $7.69B |
| Long-Term Debt | $14.66M | $17.67B |
| Total Shareholders Equity | $352.62M | $25.24B |
| Retained Earnings | $-335.55M | $16.15B |
| Property, Plant & Equipment | $13.22M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BLFS | BDX |
|---|---|---|
| Operating Cash Flow | $6.04M | $941.00M |
| Capital Expenditures | $-175,000 | N/A |
| Free Cash Flow | $1.55M | $35.00M |
| Debt Repayment | $-2.50M | $-1.00M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | BLFS | BDX |
|---|---|---|
| Shares Short | 3.93M | 4.28M |
| Short Ratio | 8.26 | 2.41 |
| Short % of Float | 0.12% | 0.02% |
| Average Daily Volume (10 Day) | 345,300 | 1,365,580 |
| Average Daily Volume (90 Day) | 384,577 | 1,558,670 |
| Shares Outstanding | 46.91M | 289.10M |
| Float Shares | 39.41M | 286.00M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.05% | 0.92% |
Dividend Analysis & Yield Comparison: Biolife Solutions vs Becton, Dickinson
| Metric | BLFS | BDX |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.80% |
| 3-Year Avg Annual Dividend | N/A | $3.16 |
| 3-Year Avg Dividend Yield | N/A | 0.40% |
| 3-Year Total Dividends | N/A | $9.48 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |